SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-323748
Filing Date
2018-11-09
Accepted
2018-11-09 16:01:05
Documents
3
Period of Report
2018-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d615667d8k.htm 8-K 16961
2 EX-99.1 d615667dex991.htm EX-99.1 42879
3 GRAPHIC g615667g1109094446727.jpg GRAPHIC 4527
  Complete submission text file 0001193125-18-323748.txt   67413
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Filer) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36183 | Film No.: 181173025
SIC: 2836 Biological Products, (No Diagnostic Substances)